Clinical trial data from the SUSTAIN and STEP programs indicate that nausea, the most frequently reported side effect, generally improves within 46 weeks for most patients as tolerance develops
You wont magically lose weight or improve your blood sugar markers without changing your diet
Comorbidities included hypertensive diseases (I10-I16), Type 2 diabetes mellitus (E11), chronic lower respiratory diseases (J40-J47), neoplasms (C00-D49), psychoactive substance use (F10-F19), ischemic heart diseases (I20-I25), chronic kidney disease (N18), and cerebrovascular diseases (I60-I69)
(Imagine: being able to stop at one cookie
Some patients respond very well to semaglutide, while others may respond better to tirzepatide
Ozempic (semaglutide) : Ozempic is a weekly injectable medication FDA-approved for managing blood sugar levels in adults with type 2 diabetes mellitus